Company profile: RootPath
1.1 - Company Overview
Company description
- Provider of a personalized T cell therapy platform and gene synthesis solutions, including PathFinder DNA Assembly™ for accurate long-gene construction, Molecular Toothpick™ for error screening and recovery, PathFinder Custom Gene Library™ with sequence-verified plasmids, genes and fragments at scale (300 bp–10 kb), mutagenesis and variant libraries, and recombinant antibodies with CHO-cell expression and characterization.
Products and services
- Genes and Fragments at Scale: Length-specified service that delivers gene synthesis from 300 bp to 10 kb with quick lead times and competitive pricing for scaled projects
- Molecular Toothpick™: Error-correcting technology that screens synthetic genes for sequence errors and selectively recovers error-free molecules, markedly improving gene synthesis fidelity
- PathFinder DNA Assembly™: High-accuracy system that assembles short DNA strands into long genes, enabling large-scale gene synthesis
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RootPath
Rancho BioSciences
HQ: United States
Website
- Description: Provider of fee-for-service life science data curation and knowledge management, leveraging open-source tools and public domain data for Pharma, non-profit foundations, and academia. Services include data curation, data governance and models, bioinformatics analysis (including genetic variant annotation), workflows and pipelines, knowledge mining, and creation of target profiles to support research and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rancho BioSciences company profile →
WellGen
HQ: United States
Website
- Description: Provider of plant-based wellness products discovered and developed using nutrigenomics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WellGen company profile →
Epistem
HQ: United Kingdom
Website
- Description: Provider of specialist contract research services supporting drug discovery and development, offering preclinical in vitro/in vivo models in oncology, inflammatory and gastrointestinal diseases (incl. GI toxicities); GCLP-accredited clinical trial support (histology, IHC, image analysis, gene expression, DNA genotyping); organoid models; cancer stem cell sphere assays; subcutaneous xenografts; orthotopic/metastatic bioluminescent models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epistem company profile →
Syngenta
HQ: Switzerland
Website
- Description: Provider of agricultural technologies and solutions that improve yields, crop resilience, and resource conservation. Offers crop protection from sowing to harvest; seeds and traits for grains, oilseeds, vegetables, fruits, and flowers; TYMIRIUM technology against nematodes and soil-borne pathogens; PERGADO Ultra fungicide for cocoa; and Shoots by Syngenta, a collaborative platform advancing sustainable agriculture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syngenta company profile →
Mitotyping Technologies
HQ: United States
Website
- Description: Provider of forensic DNA analysis services for the criminal justice system, forensic laboratories, and anthropological applications, including mitochondrial DNA testing from small samples such as 2mm hair fragments or single teeth.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mitotyping Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RootPath
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RootPath
2.2 - Growth funds investing in similar companies to RootPath
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RootPath
4.2 - Public trading comparable groups for RootPath
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →